The presence of inflammatory proteins was associated with comorbidity burden and deteriorating heart function in patients with heart failure with preserved ejection fraction, according to a Northwestern Medicine study.
The Northwestern University Clinical and Translational Sciences (NUCATS) Institute hosted the first virtual COVID-19 symposium, which gave the Northwestern research community an opportunity to learn about efforts to advance public health and respond to the COVID-19 pandemic.
Feinberg principal investigators secured a record-breaking $643 million in research funding and awards during the 2019-2020 fiscal year.
At Northwestern Medicine, various COVID-19 antibody testing efforts have been underway since the beginning of the pandemic.
A novel heart failure drug called sacubitril-valsartan reduced the risk of hospitalizations for heart failure and death from cardiovascular causes more in women than in men, according to a study published in Circulation.
Risk of relapse for chronic myeloid leukemia patients may be reduced through drug combination after discontinuing initial therapy, according to a Northwestern Medicine study published in the journal Leukemia.
Elagolix, a newly developed orally administered drug, was effective in reducing heavy menstrual bleeding in women with uterine fibroids, according to a recent Northwestern Medicine clinical trial.
These images illustrate the physical reality Northwestern scientists work within, striving to uncover the mysteries of biology, chemistry and medicine.
Deaths related to choking on objects in children and adolescents — especially among children younger than three years old — have decline steadily for 50 years, according to a study published in JAMA.
Mike Boctor, a first-year student, combined his passions for film and medicine by directing an award-winning short film about the healing process for survivors of sexual assault.